Abivax SA American Depositary Shares (ABVX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $7.32B
Last updated: Nov 17, 2026 at 4:36 PM ET
Abivax SA American Depositary Shares (ABVX) Statistics
Abivax SA American Depositary Shares (ABVX) has a market cap of $7.32B. Its share count is up 25.61% from a year earlier. Revenue fell 121.42% over the last 12 months from the 12 months before.
Total Valuation
| Market Cap | $7.32B |
|---|---|
| Latest price (Nov 17, 2026) | $82.10 |
Key Dates
The next earnings report is expected on Dec 21, 2026, covering the quarter ending Sep 30, 2026.
| Next Earnings Date | Dec 21, 2026 (expected) |
|---|---|
| Last Earnings Date | Sep 21, 2026 |
| Fiscal Year End | December |
Valuation Ratios
| P/B Ratio | 15.6x |
|---|---|
| P/TBV Ratio | 16.8x |
Price Statistics
The stock is down 25.63% over 52 weeks and trades 12.18% below its 50-day average.
| Beta (1Y) | 1.20 |
|---|---|
| 52-Week Change | -25.63% |
| 1-Month Change | -6.16% |
| 3-Month Change | -31.90% |
| 6-Month Change | -27.81% |
| Total Return (1Y) | -25.63% |
| Total Return (3Y CAGR) | +95.22% |
| Return vs SPY (1Y) | -39.43% |
| Max Drawdown (1Y) | -50.11% |
| Max Drawdown (3Y) | -67.46% |
| Sharpe Ratio (1Y) | -0.36 |
| Correlation with SPY (1Y) | 0.18 |
| 50-Day Average | $93.49 |
| 200-Day Average | $112.28 |
| 52-Week Range | $69.81 to $148.83 |
| RSI (14 Days) | 38.2 |
| Average Volume (20 Days) | 767.45K |
Financial Position
Current assets cover 5.97x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 5.97x |
|---|---|
| Quick Ratio | 5.97x |
| Debt / Equity | 0.00x |
| Interest Coverage | -25.13x |
Returns and Efficiency
Return on invested capital is -159.61% over the last 12 months, against a 5-year average of -55.88%.
| Return on Equity (ROE) | -169.24% |
|---|---|
| Return on Assets (ROA) | -134.11% |
| Return on Invested Capital (ROIC) | -159.61% |
| Return on Capital Employed (ROCE) | -147.11% |
| ROA (5Y Average) | -61.57% |
| ROIC (5Y Average) | -55.88% |
Scores
ABVX has a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 3 of 9 |
|---|---|
| Piotroski Strength | Average |
Income Statement
Revenue was EUR -2.02M over the last 12 months.
| Revenue | EUR -2.02M |
|---|---|
| Revenue Growth (YoY) | -121.42% |
| Operating Income | EUR -420.61M |
| Pretax Income | EUR -606.95M |
| Net Income | EUR -606.95M |
| EBIT | EUR -574.50M |
Trailing 12 months through Jun 30, 2026.
Balance Sheet
Shareholder equity funds 79.24% of the EUR 462.21M in total assets.
| Working Capital | EUR 355.94M |
|---|---|
| Shareholder Equity | EUR 366.27M |
| Tangible Book Value | EUR 341.24M |
| Total Assets | EUR 462.21M |
| Total Liabilities | EUR 95.94M |
Balance sheet as of Jun 30, 2026.
Cash Flow
After EUR 174.00K of capital spending, operating cash flow left EUR -245.25M of free cash flow.
| Operating Cash Flow | EUR -245.07M |
|---|---|
| Capital Expenditures | EUR 174.00K |
| Free Cash Flow | EUR -245.25M |
| Depreciation and Amortization | EUR 1.38M |
Trailing 12 months through Jun 30, 2026.
Peer Position
Against 6 similar companies, ABVX has the 5th highest ROIC.
ROICPeer median -35.59%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +54.16%
| ROIC | -159.61% vs -35.59% median |
|---|---|
| Revenue Growth (Trailing 4 Quarters, YoY) | -121.42% vs +54.16% median |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About ABVX
What is ABVX's market cap?
Abivax SA American Depositary Shares has a market cap of $7.32B.
How many shares of ABVX are outstanding?
Abivax SA American Depositary Shares has 79.65M shares outstanding. The count is up 25.61% from a year earlier.
Does ABVX pay a dividend?
No. Abivax SA American Depositary Shares does not pay a dividend.
ABVX pages: Overview, Charting, Financials, Statistics, Competitors